FCRL5 and neoplasm: As a result, we opted to evaluate the anti-tumor efficacy of FcRH5 CAR-T cells in a disseminated MM xenografts model established by intravenously inoculating luciferase-expressing MM.1s-FcRH5 cells into NOG mice (Fig. 4a).